Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Tumour”

5,205 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 5,205 results

Early research (Phase 1)Study completedNCT00486356
What this trial is testing

Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more
University of Nebraska 46
Testing effectiveness (Phase 2)Study completedNCT03776812
What this trial is testing

Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Recurrent Ovarian CancerRecurrent Fallopian Tube CarcinomaRecurrent Primary Peritoneal Carcinoma
Corcept Therapeutics 178
Early research (Phase 1)Ended earlyNCT00030381
What this trial is testing

Iododoxorubicin in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Primary Systemic Amyloidosis
National Cancer Institute (NCI) 22
Not applicableStudy completedNCT06231537
What this trial is testing

Visual Oral Examination for Early Detection of Oral Cancer in High-Risk Individuals

Who this might be right for
Mouth Neoplasms
Universidade Federal do Rio de Janeiro 1,152
Large-scale testing (Phase 3)Looking for participantsNCT06989112
What this trial is testing

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Who this might be right for
Endometrial Cancer
AstraZeneca 600
Not applicableStudy completedNCT03082807
What this trial is testing

Dietary Guide in Active Older Adult Men

Who this might be right for
MenDiet ModificationObesity+3 more
P.L.Shupik National Medical Academy of Post-Graduate Education 37
Testing effectiveness (Phase 2)Study completedNCT00003853
What this trial is testing

4'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Study completedNCT00267865
What this trial is testing

Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma

Who this might be right for
AIDS-Related-Primary Central Nervous System Lymphoma
National Cancer Institute (NCI) 12
Not applicableLooking for participantsNCT06692972
What this trial is testing

The Regression Pattern of Primary Lesions in Lung Cancer After Definitive Radiotherapy

Who this might be right for
Lung Cancer
China-Japan Friendship Hospital 500
Testing effectiveness (Phase 2)Study completedNCT00003565
What this trial is testing

Docetaxel in Treating Patients With Solid Tumors

Who this might be right for
Bladder CancerBreast CancerHead and Neck Cancer+2 more
Alliance for Clinical Trials in Oncology 109
Early research (Phase 1)Study completedNCT01031901
What this trial is testing

Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1)

Who this might be right for
Tuberous SclerosisNeurofibromatosesAngiofibroma+1 more
The University of Texas Health Science Center, Houston 52
Not applicableNot Yet RecruitingNCT06937281
What this trial is testing

SABR PRIMER - Evaluating Stereotactic Ablative Radiotherapy for Primary and Regional Breast Tumors

Who this might be right for
Breast CancerMetastases
British Columbia Cancer Agency 40
Testing effectiveness (Phase 2)Study completedNCT00639509
What this trial is testing

IMC-A12 in Treating Patients With Advanced Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT00040898
What this trial is testing

Sho-Saiko-To Following Removal of Liver Cancer By Embolization in Treating Patients With Liver Cancer That Cannot Be Surgically Removed

Who this might be right for
Liver Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Study completedNCT03037385
What this trial is testing

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

Who this might be right for
RET-altered Non Small Cell Lung CancerMedullary Thyroid CancerRET-altered Papillary Thyroid Cancer+37 more
Hoffmann-La Roche 590
Large-scale testing (Phase 3)Study completedNCT00006799
What this trial is testing

Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer

Who this might be right for
AnorexiaCachexiaHead and Neck Cancer+1 more
Wake Forest University Health Sciences 13
Not applicableStudy completedNCT03281499
What this trial is testing

Transoral Robotic Surgery and Tailored Radiotherapy in Unknown Primary and Small Squamous Cell Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell Carcinoma
University Health Network, Toronto 22
Testing effectiveness (Phase 2)Study completedNCT00072267
What this trial is testing

UCN-01 and Topotecan in Treating Patients With Recurrent, Persistent, or Progressive Advanced Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
University Health Network, Toronto
Early research (Phase 1)Looking for participantsNCT07179328
What this trial is testing

Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard Chemotherapy

Who this might be right for
GBMGlioblastoma Multiforme (GBM)Glioblastoma Multiforme of Brain+5 more
Sunnybrook Health Sciences Centre 10
Load More Results